TNFRSF17 and breast carcinoma: First, by analyzing a large breast cancer study (MetaBRIC study), we found that APRIL (TNFSF13), BAFF (TNFSF13B), and BCMA (TNFRSF17) were expressed in 76% of the studied cohort (Figure 6A).